Chen Chen

Chen represents public and private life sciences companies in complex licensing, collaboration and strategic partnering transactions. She advises clients on research and development collaborations, license and option agreements, venture-backed NewCo transactions, co-development and co-commercialization arrangements, profit-sharing structures and territory-specific transactions. Drawing on her scientific background, Chen advises clients across therapeutic modalities and technologies, bringing an understanding of the underlying science to transactions involving complex intellectual property. She also has significant experience in cross-border transactions involving companies, investors and technologies in the US and Asia.